Related Experiment Videos

Reduced ouabain-sensitive potassium entry as a possible mechanism of multidrug-resistance in P388 cells

A Ramu1, N Ramu, R Gorodetsky

  • 1Department of Oncology, Hadassah University Hospital, Jerusalem, Israel.

Biochemical Pharmacology
|October 9, 1991
PubMed

Insights

Multidrug-resistant cells exhibit resistance to various cationic compounds. Verapamil can overcome this resistance, suggesting altered ion transport mechanisms contribute to multidrug resistance.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Biochemistry

Background:

  • Multidrug resistance (MDR) is a significant challenge in cancer therapy.
  • P388 cells exhibit resistance to anthracyclines and vinca alkaloids.
  • Cationic lipophilic compounds are also affected by multidrug resistance.

Purpose of the Study:

  • To investigate the resistance mechanisms of multidrug-resistant P388 cells to cationic compounds.
  • To explore the role of ion transport in multidrug resistance.
  • To determine if verapamil can circumvent resistance to these compounds.

Main Methods:

  • Testing resistance of multidrug-resistant P388 cells to ammonium, phosphonium, and arsonium compounds.
  • Assessing the effect of verapamil on drug resistance.
  • Measuring K+ uptake and Mg-ATPase activity in drug-sensitive and resistant cells.
  • Investigating the furosemide-sensitive transport system and Na(+)-K+ pump activity.

Main Results:

  • Multidrug-resistant P388 cells showed resistance to various cationic compounds.
  • Verapamil successfully circumvented this resistance, similar to its effect on anthracyclines and vinca alkaloids.
  • Drug-resistant cells displayed ouabain-resistant K+ uptake and Mg-ATPase activity.
  • Intracellular K+ levels were maintained by increased furosemide-sensitive transport.
  • Reduced electrogenic Na(+)-K+ pump activity correlated with lower transmembrane potential.

Conclusions:

  • Altered ion transport, specifically reduced Na(+)-K+ pump activity, contributes to multidrug resistance in P388 cells.
  • The decreased transmembrane potential in resistant cells may lead to reduced accumulation of cationic lipophilic drugs.
  • Verapamil's ability to overcome resistance highlights the potential of targeting ion transport in MDR therapies.

Related Concept Videos